Tobramycin 300 mg/5 ml Inhalation Solution Supplier in India
Looking for a Tobramycin 300 mg/5 ml inhalation solution supplier in India for a hospital, respiratory clinic, pharmacy, or distribution requirement? With inhaled medicines, getting the right product is only the beginning. You also need to check the exact strength, dosage form, pack details, availability, storage requirements, batch information, and delivery schedule. For healthcare buyers, having those details clear before placing an order can prevent unnecessary delays later.
What is Avitobra?
Avitobra is Aarokiyam’s inhalation therapy product containing Tobramycin 300 mg/5 ml. It is designed for administration by inhalation through a nebuliser. Aarokiyam presents Avitobra as part of its respiratory product portfolio.
Tobramycin is an aminoglycoside antibiotic. The 300 mg/5 ml inhalation solution is primarily associated with the management of cystic fibrosis in patients with Pseudomonas aeruginosa, according to current prescribing information.
So, if your requirement is for an inhaled antibiotic, do not confuse an inhalation solution with injectable or ophthalmic tobramycin products. The route of administration matters.
When is Tobramycin Inhalation Solution used?
A question we often see around inhaled antibiotics is, “Is this just another medicine for a chest infection?” Not quite. Tobramycin inhalation solution is specifically used in appropriate patients with chronic pulmonary infection associated with Pseudomonas aeruginosa, particularly in cystic fibrosis.
That means it is relevant to specific respiratory situations rather than every case of cough, cold, bronchitis, or pneumonia. For healthcare professionals, the patient’s diagnosis, microbiology results and treatment plan remain important when deciding whether inhaled tobramycin is appropriate.
What respiratory conditions are associated with inhaled tobramycin?
Depending on the patient’s clinical situation, healthcare teams may consider inhaled antibiotic therapy where there is a chronic bacterial infection of the lungs.
Important terms buyers may come across include:
- Cystic fibrosis: A long-term condition in which thick mucus can contribute to repeated lung infections.
- Pseudomonas aeruginosa infection: A bacterial infection that can become persistent in the respiratory tract, particularly in people with underlying lung disease.
- Chronic lung infections: Recurring or persistent bacterial infections requiring an ongoing treatment strategy.
- Bronchiectasis: A chronic lung condition associated with widened airways and recurrent respiratory infections. Whether inhaled tobramycin is appropriate depends on the individual patient and prescribing guidance.
- The key point is simple: the medicine is selected for a specific clinical reason. It is not a general-purpose lung infection treatment for every respiratory complaint.
Why does the 300 mg/5 ml strength matter?
When ordering medicines, numbers can look like minor details until the wrong presentation arrives. For this product, 300 mg/5 ml describes the concentration of tobramycin in the inhalation solution. Current product information identifies a 300 mg/5 ml nebuliser presentation for inhalation use. Before confirming your order, check the complete product description rather than relying only on the word “Tobramycin.”
You should confirm:
- Active ingredient and strength
- Inhalation route
- Pack size
- Current batch and expiry
- Storage conditions
- Required quality or product documents
- Delivery location and quantity
This is especially useful when your purchasing team is comparing several suppliers offering different forms of the same medicine.
Tobramycin Respules Bulk Supplier in India: what should hospitals check?
A large hospital order deserves a little more attention than a quick retail purchase.
Suppose your pharmacy requires several packs for respiratory care. Before you approve the quotation, ask the supplier:
- Is the 300 mg/5 ml presentation currently available?
- What batch is being supplied?
- What is the pack configuration?
- How much shelf life remains?
- What storage conditions apply?
- What documentation will accompany the supply?
- When can the order reach the required location?
These questions help you compare suppliers on something more meaningful than price alone.
How does Avitobra fit into Aarokiyam's portfolio?
We are an Indian pharmaceutical research and marketing company established in 2024. Our website includes Avitobra under our inhalation therapy products and describes us as the supplier and marketer of the product rather than the manufacturer.
For hospitals, distributors and healthcare institutions, the practical approach is to share your exact requirement with our team.
Tell us:
- Product: Avitobra
- Composition: Tobramycin 300 mg/5 ml
- Requirement: Number of packs or units
- Buyer type: Hospital / distributor / institution
- Delivery location: City and state
- Documentation: Your required product or batch documents
- Timeline: Desired delivery date
A clear enquiry gives both sides a better starting point.
What makes a good inhalation medicine supplier?
You do not need a complicated scoring system. Start with the basics.
Product accuracy: Is the exact inhalation presentation available?
Stock visibility: Can the supplier tell you what is currently available?
Shelf life: Is there enough remaining expiry for your planned use?
Documentation: Can the supplier provide the information your procurement team needs?
Delivery: Can the order be supplied to your location within the required timeframe?
For recurring hospital requirements, consistency can be just as important as the first quotation.
Is nebulised antibiotic treatment the same as an injection?
No. The route is different. Avitobra containing Tobramycin 300 mg/5 ml is an inhalation solution intended for administration through a nebuliser. An injectable tobramycin product is a different dosage form with a different route and clinical use.
That distinction should be made clearly when ordering, especially when multiple tobramycin products are listed by different suppliers.
FAQs
Aarokiyam Lifesciences handles enquiries for Avitobra, its Tobramycin 300 mg/5 ml inhalation solution. Hospitals, distributors and healthcare institutions can contact the company with their product and quantity requirements.
Avitobra contains inhaled Tobramycin 300 mg/5 ml. Inhaled tobramycin is primarily used for the management of chronic pulmonary infection associated with Pseudomonas aeruginosa in appropriate patients with cystic fibrosis.
Yes. Current prescribing information specifically identifies Tobramycin 300 mg/5 ml inhalation solution for adults and children aged 6 years and older with cystic fibrosis and Pseudomonas aeruginosa.
No. Inhaled tobramycin is intended for specific bacterial respiratory infections and should be used according to medical assessment and prescribing information.
Yes. Avitobra is an inhalation therapy product, and Aarokiyam describes it for use through a nebuliser.
Contact Us
Want to discuss bulk orders?
Please complete the online form if you have any questions or would like to talk about large orders. When you require any information, our employees will get back to you right away. To satisfy your healthcare demands, we at Aarokiyam Lifescience are dedicated to offering top-notch products and outstanding service.
Discover the Aarokiyam difference, where compassionate care and cutting-edge inhalation therapies combine to bring better health to life.